Escolar Documentos
Profissional Documentos
Cultura Documentos
CNPJ/ME nº 12.104.241/0004-02
NIRE 35.300.493.699
Companhia Aberta
FATO RELEVANTE
O Sistema Unimed é atualmente composto por mais de 340 cooperativas independentes, totalizando
aproximadamente 18,5 milhões de beneficiários e perfazendo o maior contingente de vidas cobertas pela
saúde suplementar no Brasil. A expertise e especialização da Oncoclínicas na condução de toda a jornada
oncológica, aliadas ao conhecimento da UN na gestão assistencial com excelência e eficiência, se somam
nessa nova iniciativa.
A JV Unimed Nacional terá uma composição acionária de pelo menos 50,01% para a Oncoclínicas e de até
49,99% para a UN, a depender da alocação de capital requerida para as futuras parcerias ou acordos
comerciais de longo prazo que venham a ser firmados entre a JV Unimed Nacional e cada Unimed singular
que optar por se associar a ela.
Cristiano Camargo
Diretor de Relações com Investidores
ONCOCLÍNICAS DO BRASIL SERVIÇOS MÉDICOS S.A.
ONCOCLÍNICAS DO BRASIL SERVIÇOS MÉDICOS S.A.
CNPJ/ME nº 12.104.241/0004-02
NIRE 35.300.493.699
Publicly Traded Company
Material Fact
Oncoclínicas and UN have jointly developed a comprehensive line of care model for cancer patients, focused
on treatment excellence and cost effectiveness. This model, which has been under constant evolution over
the last years, as a result of a successful partnership, is now available to all medical coops part of the
Unimed System that may choose to implement it, across the entire Brazil.
The Unimed System is currently comprised of more than 340 independent cooperatives, adding to
approximately 18.5 million beneficiaries, and making up the largest number of lives covered by the private
health insurance sector in Brazil. The expertise and specialization of Oncoclínicas across the entire oncology
journey, and the knowledge of UN in care management with excellence and efficiency all come to bear
under this new initiative.
The Unimed Nacional JV will have an ownership structure of at least 50.01% for Oncoclínicas and up to
49.99% for UN, depending on the capital allocation required for future partnerships or long-term
commercial agreements that may be entered into between Unimed Nacional JV and each Unimed coop that
chooses to associate with the new venture.
The closing of the Transaction is subject to the signing of the definitive documents and the satisfaction of
certain conditions precedent, including, but not limited to, the approval of the Administrative Council for
Economic Defense - CADE. The Company will keep the market informed of any relevant updates related to
the matters herein presented.
Cristiano Camargo
Investor Relations Officer
ONCOCLÍNICAS DO BRASIL SERVIÇOS MÉDICOS S.A.